Table 6.
Plasma renin activity determinations and BP in patients with atherosclerotic renal artery stenosis at 3 months after revascularization or medical therapy
| Parameter | 3 mo | P Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Stent STK, n=10 | Stent CLK, n=10 | P Value | Medical STK, n=20 | Medical CLK, n=20 | P Value | 3 mo Versus Baseline Stent STK | 3 mo Versus Baseline Stent CLK | 3 mo Versus Baseline Medical STK | 3 mo Versus Baseline Medical CLK | |
| Single–kidney vein PRA, ng/ml per 1 h | 9.3±10.6 | 9.3±9.3 | 0.90 | 19.2±18.4 | 15.7±14.1 | 0.03 | 0.01 | 0.02 | 0.80 | 0.90 |
| P Value Stent Versus Medical Group | 3 mo Versus Baseline Stent Group | 3 mo Versus Baseline Medical Group | ||||
|---|---|---|---|---|---|---|
| PRA IVC, ng/ml per 1 h | 6.7±8.3 | 14.6±14.6 | 0.30 | 0.01 | 0.70 | |
| SBP, mmHg | 130.2±14.5 | 133.6±19.1 | 0.90 | 0.04 | 0.90 | |
| DBP, mmHg | 64.9±10.3 | 67.1±12.2 | 0.60 | 0.08 | 0.90 |
Data are means±SDs. STK, stenotic kidney; CLK, contralateral kidney; PRA, plasma renin activity; IVC, inferior vena cava; SBP, systolic BP; DBP, diastolic BP.